|
Q3 FY2024
As of Jan 31, 2024
|
Q2 FY2024
As of Oct 31, 2023
|
Q1 FY2024
As of Jul 31, 2023
|
Q4 FY2023
As of Apr 30, 2023
|
Q3 FY2023
As of Jan 31, 2023
|
Q2 FY2023
As of Oct 31, 2022
|
Q1 FY2023
As of Jul 31, 2022
|
Q4 FY2022
As of Apr 30, 2022
|
Q3 FY2015
As of Jan 31, 2015
|
Q2 FY2015
As of Oct 31, 2014
|
Q1 FY2015
As of Jul 31, 2014
|
Q4 FY2014
As of Apr 30, 2014
|
Q3 FY2014
As of Jan 31, 2014
|
Q2 FY2014
As of Oct 31, 2013
|
Q1 FY2014
As of Jul 31, 2013
|
Q4 FY2013
As of Apr 30, 2013
|
Q3 FY2013
As of Jan 31, 2013
|
Q2 FY2013
As of Oct 31, 2012
|
Q1 FY2013
As of Jul 31, 2012
|
Q4 FY2012
As of Apr 30, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Deposits and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Advances - related party | ||||||||||||||||||||
| Advances | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| President | ||||||||||||||||||||
| Officer | ||||||||||||||||||||
| Derivative Liability | ||||||||||||||||||||
| Convertible debt, related party, net of discount | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
| Common stock, no par value, 172,500,000 shares authorized, 172,214,579 and 152,289,579 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total liabilities and stockholders’ deficit | ||||||||||||||||||||
Loading...
